KemPharm, a specialty pharmaceutical company based in Coralville, entered a new licensing agreement with an affiliate of Gurnet Point Capital (GPC), a private investment firm focused on the life sciences and medtech sectors, reports the Corridor Business Journal. The agreement provides GPC’s affiliate with an exclusive worldwide license to develop, manufacture and commercialize KemPharm’s product candidates […]